Cargando…
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
OBJECTIVE: To determine whether neurofilament light chain protein in CSF (cNfL), a sensitive biomarker of neuroaxonal damage, reflects disease severity or can predict survival in Parkinson disease (PD). METHODS: We investigated whether disease severity, phenotype, or survival in patients with new-on...
Autores principales: | Bäckström, David, Linder, Jan, Jakobson Mo, Susanna, Riklund, Katrine, Zetterberg, Henrik, Blennow, Kaj, Forsgren, Lars, Lenfeldt, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605503/ https://www.ncbi.nlm.nih.gov/pubmed/32680941 http://dx.doi.org/10.1212/WNL.0000000000010084 |
Ejemplares similares
-
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study
por: Bäckström, David, et al.
Publicado: (2018) -
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study
por: Bäckström, David, et al.
Publicado: (2022) -
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
por: Hansson, Oskar, et al.
Publicado: (2017) -
Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013) -
Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds
por: Dittrich, Anna, et al.
Publicado: (2022)